Lilly's Commitment to Global Innovation Reinforced with Opening of New Diabetes-Focused Research and Development Center in Shanghai
17:15 EDT 30 May 2012 | PR Newswire
This article has expired, however you can still
download the PDF.
Preview:
SHANGHAI, May 30, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced it has officially opened the Lilly China Research and Development Center (LCRDC), a key component of its significant and sustainable commitment to China. The goal...
Other Sources for this Article
More From BioPortfolio on "Lilly's Commitment to Global Innovation Reinforced with Opening of New Diabetes-Focused Research and Development Center in Shanghai"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
